ANKRD13C expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 7.5529000054253E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.53480000000461E-05 |
Normal-vs-Stage2 |
1.112600E-01 |
Normal-vs-Stage3 |
3.71530000000675E-05 |
Normal-vs-Stage4 |
7.53920004203934E-09 |
Stage1-vs-Stage2 |
7.286800E-01 |
Stage1-vs-Stage3 |
1.651440E-01 |
Stage1-vs-Stage4 |
1.009870E-02 |
Stage2-vs-Stage3 |
2.436800E-01 |
Stage2-vs-Stage4 |
1.106180E-01 |
Stage3-vs-Stage4 |
5.446200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.42829999996808E-07 |
Normal-vs-AfricanAmerican |
1.59576999999578E-05 |
Normal-vs-Asian |
1.437570E-01 |
Caucasian-vs-AfricanAmerican |
3.032400E-01 |
Caucasian-vs-Asian |
7.405400E-01 |
AfricanAmerican-vs-Asian |
3.903400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.92419999933691E-08 |
Normal-vs-Female |
5.229900E-04 |
Male-vs-Female |
7.074200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.60500000000652E-05 |
Normal-vs-Age(41-60Yrs) |
2.30900000000034E-05 |
Normal-vs-Age(61-80Yrs) |
1.62270000003684E-06 |
Normal-vs-Age(81-100Yrs) |
3.636800E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.102600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.683400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.829800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.231200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.216800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.913200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.111400E-01 |
Normal-vs-Grade 2 |
2.393800E-02 |
Normal-vs-Grade 3 |
1.32139965636213E-10 |
Normal-vs-Grade 4 |
5.98554539266161E-12 |
Grade 1-vs-Grade 2 |
4.902000E-01 |
Grade 1-vs-Grade 3 |
1.922200E-02 |
Grade 1-vs-Grade 4 |
1.119110E-03 |
Grade 2-vs-Grade 3 |
1.021180E-03 |
Grade 2-vs-Grade 4 |
3.44659999995667E-06 |
Grade 3-vs-Grade 4 |
2.895900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
6.389800E-02 |
Normal-vs-ccB subtype |
5.52569999756614E-08 |
ccA subtype-vs-ccB subtype |
3.212400E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.74869999999872E-05 |
Normal-vs-N1 |
1.708330E-02 |
N0-vs-N1 |
4.148000E-01 |
|
|